WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 4147

Legislative bill overview

HB 4147 would require informed consent procedures for certain screening tests in Texas, though the bill's specific text is not publicly available yet given its recent filing. The measure appears to establish requirements that healthcare providers obtain explicit patient consent before administering particular screening tests, with defined disclosure standards.

Why is this important

Informed consent requirements affect the balance between preventive health screening and patient autonomy. They can influence screening rates, healthcare costs, and patient trust in medical procedures, while also potentially creating administrative burdens on healthcare systems and affecting early disease detection outcomes.

Potential points of contention

  • Scope of tests covered: Unclear which specific screening tests trigger the requirement, potentially affecting common procedures like cancer screenings, genetic tests, or infectious disease screening
  • Implementation burden: Healthcare providers may face increased administrative costs and time requirements to document consent, potentially delaying care
  • Unintended health consequences: Expanded consent requirements could reduce screening rates among vulnerable populations or those with limited health literacy, potentially delaying disease diagnosis

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.